The distribution of a subspecies of protein kinase C (PKC) encoded by the P8n sequence in rat central nervous tissue was demonstrated immunocytochemically by using antibodies raised against an oligopeptide having a partial sequence specific for the p& PKC. The pn PKC immunoreactivity was widely but discretely distributed in the brain. The distribution of the Pu PKC immunoreactivity differed from that of the P1 and y PKC subspecies. The PHn PKC immunoreactivity was found in the perikarya, dendrites, and axons of neuronal cells. Few if any glial cells were stained. Immunoreactive neurons were present in the anterior olfactory nucleus, olfactory tubercle, amygdaloid complex, caudate-putamen, accumbens nucleus, claustrum, dorsal part of the lateral septal nucleus, CA1 region of the hippocampus, subiculum, medial habenular nucleus, cerebral cortex, nucleus of the spinal tract of the trigeminal nerve, nucleus of the solitary tract, and substantia gelatinosa of the spinal cord. In these neurons, the PI PKC immunoreactivity was seen mainly in the form of cytoplasmic dots and, in some cases, diffusely in the cytoplasm. Under electron microscopy, these immunoreactive large dots appeared to be associated with the Golgi complex, suggesting that the PBII PKC plays a specialized function at the Golgi complex in certain neuronal cell types.
acylglycerol in the presence of Ca2l and phospholipids, acts as a key enzyme for signal transduction in various physiological processes (1) (2) (3) . Recent molecular cloning studies have revealed that PKC is a large family consisting of at least seven subspecies (a, 1 PI, y, 8, E, and O) with closely related but distinct structures (3) . Enzymological studies have shown that PKC can be resolved into three distinct fractions, types I-III, by hydroxyapatite column chromatography (4) . Com- parison of these fractions with the enzymes expressed in COS-7 cells transfected by the respective cDNA-containing plasmids (5, 6) has indicated that PKC types I, II, and III are products of y, f, and a genes, respectively. Distribution of these three subspecies has been studied by biochemical and immunocytochemical procedures (7) (8) (9) (10) (11) (12) (13) . The y (type I) PKC is found only in the neurons of the central nervous system, whereas the P8 and PII (type II) PKC and a (type III) PKC are detected in both central and peripheral tissues (7, (14) (15) (16) . The enzymological properties of the 8, E, and C PKC subspecies have not been defined.
The Pu and PuI PKC subspecies differ from each other only in short sequences in their carboxyl-terminal regions. A previous report (12) described antibodies against the PII PKC, which were prepared by immunization with a synthetic oligopeptide, representing the specific sequence in this region, conjugated to bovine thyroglobulin with carbodiimide.
The antibodies reacted specifically with ,BI PKC The carboxyl-terminal portion of the PI, PKC (residues 660-673: Ser-Phe-Val-Asn-Ser-Glu-Phe-Leu-Lys-Pro-Glu-ValLys-Ser) was selected as an amino acid sequence specific to the PII PKC. The oligopeptide was synthesized and coupled to bovine serum albumin by glutaraldehyde (17) . The product was mixed with complete Freund's adjuvant and injected intracutaneously into rabbits. The antigen, emulsified with incomplete Freund's adjuvant, was injected repeatedly at intervals of 2 weeks, and the rabbits were bled 4-6 days after each booster injection. The titer of antisera was examined by enzyme-linked immunoadsorbent assay (ELISA) as described (18) . The crude antisera with the highest titer were purified by affinity column chromatography on Sepharose CL-4B coupled to the PII oligopeptide conjugated to bovine thyroglobulin by glutaraldehyde. The specific antibodies were eluted from the column with 0.2 M glycine buffer (pH 2.2).
Preparation of PKC. Rat brain PKC was resolved into types I-III by hydroxyapatite column chromatography (5, 6) . The standard preparations of the a, PI, PII, and y subspecies of PKC were obtained from COS-7 cells that were transfected with the respective cDNA-containing plasmids as described (5, 6) .
Immunoblotting. For immunoblotting, samples were fractionated in a NaDodSO4/7.5% polyacrylamide slab gel by electrophoresis in the buffer system described by Laemmli (19) , and the proteins were transferred to nitrocellulose paper. The paper was incubated with the PII PKC-specific antibodies, and the immunoreactive bands were visualized by the peroxidase-antiperoxidase method.
Immunocytochemical Staining. Frontal sections of rat brain were prepared as described (17) Electron microscopic studies were performed as described (11) . In brief, 40-,um-thick Vibratome sections were stained as described for light microscopy without a detergent in the buffer. After incubation with osmic acid, the sections were embedded flat in Epon, and the ultrathin sections were observed with a Hitachi HS-9 electron microscope. The terminology of anatomy used here is that of Paxinos and Watson (20) .
RESULTS
Production and Characterization of Antibodies. The titer of the antisera, as examined by ELISA, was increased after the second booster administration and reached maximal levels after the fourth booster. The antisera obtained were purified as described above and used for all experiments described below.
Immunoblot analysis revealed that the purified antibodies detected an 80-kDa band corresponding to PKC in the rat brain soluble fraction (Fig. 1, lane a) and that the antibodies detected only type II but not type I or type III PKC, which were obtained from the rat brain by hydroxyapatite chromatography ( Fig. 1, lanes b-d) . Direct evidence that the antibodies react specifically with the Pu PKC was provided by immunoblotting of PKC subspecies obtained separately from the respective cDNA-transfected COS-7 cells. The antibodies stained the 8ll PKC but not the enzymes encoded by the a, 13i, and y sequences (lanes e-h).
Immunocytochemical Localization of PI, PKC. Distribution of 111 PKC immunoreactivity. The immunoreaction was widely distributed but discretely localized in the brain (Fig.  2) . The greatest density of 83u PKC immunoreactivity was seen in the olfactory tubercle, caudal part of the caudateputamen, accumbens nucleus, CA1 region of the hippocampus (strata oriens and radiatum), layer VI of the cerebral cortex, and pars compacta of the substantia nigra. A erately high density of immunoreactivity was seen in the internal plexiform layer of the olfactory bulb, anterior olfactory nucleus, basolateral and basomedial nuclei of the amygdaloid complex, rostral part of the caudate-putamen, globus pallidus, claustrum, dorsal part of the lateral septal nucleus, CA1 region of the hippocampus (stratum pyramidale), subiculum, dorsal lateral geniculate nucleus, layers I, II, III, and V of the cerebral cortex, layer VI of the cingulate cortex, layer VI of the entorhinal cortex, entopeduncular nucleus, pars reticulata of the substantia nigra, substantia gelatinosa of the spinal cord, fornix, and internal capsule. A moderate density of immunoreactivity was seen in the molecular layer of the cerebellar cortex, pyramidal tract, and corticospinal tract of the spinal tract. Other brain regions showed little or no immunoreactivity. There was no obvious immunoreaction in glial cells.
All immunoreaction was completely abolished by prior incubation of the antibodies with the immunogen (pI, oligopeptide). Normal rabbit serum failed to produce any immunoreaction (data not shown).
Characteristics of PI, PKC immunoreactivity in the neurons. Perikarya with immunoreactive material in the cytoplasm were seen in restricted areas of the rat brain such as the anterior olfactory nucleus, olfactory tubercle, amygdaloid complex, caudate-putamen, accumbens nucleus, claustrum, dorsal part of the lateral septal nucleus, CA1 region of the hippocampus, subiculum, medial habenular nucleus, layers II, III, V, and VI of the cerebral cortex, nucleus of the spinal tract ofthe trigeminal nerve, nucleus of the solitary tract, and substantia gelatinosa of the spinal cord.
In the dorsal part of the lateral septal nucleus, intense immunoreactivity was seen in large neuronal perikarya with dendritic processes (Fig. 3A) . At a higher magnification, the immunoreactive material could be seen in a dotted pattern along the plasma membrane and/or in the cytoplasm of the perikarya and dendrites but not in the nucleus (Fig. 3B) . The cells showing this type of immunoreactivity were also seen in the nucleus of the solitary tract.
In the hippocampus, which was one of the most densely stained areas, the immunoreaction was seen only in the CA1 area and not in the CA2-4 areas (Fig. 4A) . In the CA1 area, dendritic trees of the pyramidal cells in the stratum oriens and stratum radiatum were densely stained, and large immunoreactive dots were seen in the pyramidal cell layer (Fig. 4B) .
Dense immunoreaction was observed in the neuropils throughout the caudate-putamen, but poor or no immunoreactivity was observed in the fiber bundles (Fig. 4C) . Immunoreactive large dots were more abundant in the caudolateroventral region than in the rostromediodorsal region of the caudate-putamen. Immunoreactive large dots were observed in the perinuclear area of medium-sized cells (20) (21) (22) (23) (24) (25) ,um) (Fig.   4D ).
In many other neurons the I3Ii PKC immunostaining in the cytoplasm was seen as several large dots. In the neocortex, the immunoreactive material was seen as large dots mainly in the pyramidal cells through layers II, III, V, and VI, and most frequently in layer VI (Fig. 5) .
Electron microscopic observation of the cortical pyramidal cells revealed that the large immunoreactive dots observed under light microscopy were located around the Golgi complex (Fig. 6) .
In the white matter, nerve fibers were stained densely in the internal capsule and fornix, and moderately in the corpus callosum, pyramidal tract, and corticospinal tract of the spinal cord. There was, however, no or very weak immunoreaction in other nerve tracts such as the cranial nerve and optic tract. by peroxidase-antiperoxidase immunocytochemistry. Strong immunoreaction with 1l3 PKC is seen in the olfactory tubercle, caudate-putamen, accumbens nucleus, CAI region of the hippocampus (strata oriens and radiatum), neocortex, and substantia nigra. Relative density of immunoreactivity is shown according to the color table (highest density, red; lowest density, black). Acb, accumbens nucleus; AO, anterior olfactory nuclei; CAI, CAl region of the hippocampus; CPu, caudate-putamen; DG, dentate gyrus; Fr, frontal cortex; IC, internal capsule; LS, lateral septal nucleus; Mol, molecular layer of the cerebellar cortex; py, pyramidal tract; sg, substantia gelatinosa of the spinal cord; SN, substantia nigra; SuC, superior colliculus; T, thalamus; Tu, olfactory tubercle.
DISCUSSION
In the present studies we have prepared an antiserum that recognizes the f3I PKC but not the a, 81, or y PKC. The 8, E, and g subspecies do not contain the amino acid sequence of the oligopeptide employed as immunogen (21) . Theoretically, therefore, the antibodies should not react with these subspecies.
The distribution of the ,8I PKC subspecies is considerably different from that of y PKC (type I) (10, 22) or PI PKC (17) . However, the densely immunoreactive P11 PKC areas also show y PKC immunoreactivity and phorbol ester binding (23) . The findings presented here do not perfectly correspond to the immunostaining patterns of the PKC antibodies prepared by other workers (7, 9, (24) (25) (26) . Their antibodies appear to recognize other subspecies of PKC or both the f3I and Pu1 subspecies. For example, the present results confirmed that, in the rat cerebellum, the ,81 PKC is present in the molecular layer, while p3 PKC is present in the granular layer, as described previously (12, 17 (10) . In contrast, the very few P3I PKC-immunoreactive cells recognized in the hippocampus are apparently nonpyramidal cells (17) .
The distribution of PuI PKC in the hippocampus is very similar to that of the inositol 1,4,5-trisphosphate receptor, which is predominantly located in the strata oriens and radiatum in the CA1 region (28) . It is also remarkably similar to the localization of the N-methyl-D-aspartate-sensitive L-glutamate receptor (29) , which is considered to provide a basis for triggering long-term potentiation of synaptic transmission in the hippocampal CA1 region (30) . The F1/B50 protein is a neuron-specific substrate of PKC that has been implicated in long-term modulation of synaptic efficacy (31, 32) . Immunohistochemical studies have shown that this protein is also densely localized in the CA1 region of the hippocampus (33) . By in situ hybridization, the selective expression of F1/B50 mRNA has been shown in the CA1 to CA4 pyramidal cells but not in the granule cells in the hippocampus (34 
